ACM Research Inc (ACMR) concluded trading on Thursday at a closing price of $14.10, with 6.06 million shares of worth about $85.42 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -38.02% during that period and on December 05, 2024 the price saw a loss of about -14.91%. Currently the company’s common shares owned by public are about 57.52M shares, out of which, 48.61M shares are available for trading.
Stock saw a price change of -18.36% in past 5 days and over the past one month there was a price change of -22.44%. Year-to-date (YTD), ACMR shares are showing a performance of -27.84% which decreased to -12.04% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $13.94 but also hit the highest price of $34.40 during that period. The average intraday trading volume for ACM Research Inc shares is 1.42 million. The stock is currently trading -21.56% below its 20-day simple moving average (SMA20), while that difference is down -26.18% for SMA50 and it goes to -36.69% lower than SMA200.
ACM Research Inc (NASDAQ: ACMR) currently have 57.52M outstanding shares and institutions hold larger chunk of about 53.57% of that.
The stock has a current market capitalization of $883.05M and its 3Y-monthly beta is at 1.45. PE ratio of stock for trailing 12 months is 10.63, while it has posted earnings per share of $1.33 in the same period. Its PEG reads 0.53 and has Quick Ratio of 1.34 while making debt-to-equity ratio of 0.20. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ACMR, volatility over the week remained 8.52% while standing at 5.69% over the month.
Stock’s fiscal year EPS is expected to rise by 7.67% while it is estimated to increase by 5.77% in next year. EPS is likely to shrink at an annualized rate of 20.00% for next 5-years, compared to annual growth of 56.93% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Craig Hallum on Dec-06-24 offering a Hold rating for the stock and assigned a target price of $18 to it. On February 29, 2024, Goldman Upgrade their recommendations, while on July 03, 2023, Jefferies Upgrade their ratings for the stock with a price target of $23.40. Stock get an Overweight rating from Morgan Stanley on March 06, 2023.
